Loading…

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

We studied the association between RGS4 (rs951436) polymorphism and treatment response in electroconvulsive therapy (ECT) as well as risk of treatment-resistant depression. The study sample consisted of 119 patients with major depressive disorder (MDD) and 384 healthy control subjects. RGS4 polymorp...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience letters 2008-05, Vol.437 (1), p.25-28
Main Authors: Huuhka, Kaija, Kampman, Olli, Anttila, Sami, Huuhka, Martti, Rontu, Riikka, Mattila, Kari M., Hurme, Mikko, Lehtimäki, Terho, Leinonen, Esa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We studied the association between RGS4 (rs951436) polymorphism and treatment response in electroconvulsive therapy (ECT) as well as risk of treatment-resistant depression. The study sample consisted of 119 patients with major depressive disorder (MDD) and 384 healthy control subjects. RGS4 polymorphism was not associated with treatment response in ECT or risk of MDD. According to the present data, the impact of RGS4 genotype is not decisive in major depressive disorder. The results provide preliminary data on the impact of RGS4 polymorphism in treatment response in ECT.
ISSN:0304-3940
1872-7972
DOI:10.1016/j.neulet.2008.03.065